相关实验视频
Updated: Jun 25, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
在住院期间继续使用甲福明与在医院获得的并发症之间的关联
Barbara Depczynski1,2, Abbish Kamalakkannan3, Bence Siklosi4
1Department of Diabetes and Endocrinology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
概括
在住院期间继续服用甲福明可能会减少医院获得的并发症 (HAC). 这项研究发现,与没有糖尿病的患者相比,接受甲福明的患者患HAC的风险较低. 需要进一步的研究来证实这些发现.
科学领域:
- 内部医学 内部医学
- 临床药理学 临床药理学
- 糖尿病管理 糖尿病管理
背景情况:
- 甲胺是一种常见的糖尿病药物,但其在住院期间的安全性尚未得到充分证实.
- 医院获得的并发症 (HACs) 对患者的治疗结果是一个重大问题.
研究的目的:
- 评估在住院期间持续服用甲福明与发展HACs的风险之间的关联.
- 为了比较继续服用甲福林的患者与停止或不服用甲福林的患者中HACs的风险.
主要方法:
- 对患有和没有糖尿病的住院患者进行了回顾性观察性研究.
- 使用倾向分数匹配 (PSM) 来创建可比的对照组.
- 使用Kaplan-Meier生存分析和Cox比例危险模型来评估HAC风险.
主要成果:
- 与没有糖尿病的匹配对照组 (aHR 0.85) 相比,持续服用甲福明与HAC的可能性较低的趋势有关.
- 与各自的对照组相比,在入院前停止服用甲福明或没有服用甲福明的患者的HAC风险显著增加.
- HAC发生在5.5%的甲福明持续治疗组,而非糖尿病对照组的6.4%.
结论:
- 在住院期间继续服用甲福明的个人评估可能与HAC风险降低有关.
- 该研究强调需要进一步调查,因为与非糖尿病对照对照的匹配有限.
- 研究结果表明,在住院糖尿病患者中,谨慎管理甲福林的使用可能有潜在的益处.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189
Diabetes: Symptoms, Diagnosis, and Complications
523
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Acute Pancreatitis II: Clinical Manifestations and Management
118
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118
Insulin: Dosing Regimen and Adverse Effects
166
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
166
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes
920
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
920

